List of Tables:

TABLE 1 MARKET SYNOPSIS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2017 & 2023
TABLE 4 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET BY TYPE, 2015-2023 (USD Million)
TABLE 5 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AGE RELATED MACULAR DEGENERATION, BY REGION, 2015-2023 (USD Million)
TABLE 6 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY REGION, 2015-2023 (USD Million)
TABLE 7 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET BY STAGES,, 2015-2023 (USD Million)
TABLE 8 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR INTERMEDIATE AGE-RELATED MACULAR DEGENERATION(AMD),BY REGION, 2015-2023 (USD Million)
TABLE 9 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR EARLY AGE-RELATED MACULAR DEGENERATION (AMD),BY REGION, 2015-2023 (USD Million)
TABLE 10 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET BY LATE AGE-RELATED MACULAR DEGENERATION (AMD),BY REGION, 2015-2023 (USD Million)
TABLE 11 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET BY AGE GROUP, 2015-2023 (USD Million)
TABLE 12 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR ABOVE 60 YEARS, BY REGION, 2015-2023 (USD Million)
TABLE 13 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR ABOVE 40 YEARS, BY REGION, 2015-2023 (USD Million)
TABLE 14 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 15 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY REGION, 2015-2023 (USD Million)
TABLE 16 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 17 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 18 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 19 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 20 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 21 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 22 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY REGION, 2015-2023 (USD Million)
TABLE 23 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 24 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET BY ROUTE OF ADMINISTRATION, 2015-2023 (USD Million)
TABLE 25 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR INTRAVITREAL, BY REGION, 2015-2023 (USD Million)
TABLE 26 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR INTRAVENOUS, BY REGION, 2015-2023 (USD Million)
TABLE 27 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET BY END USER, 2015-2023 (USD Million)
TABLE 28 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2015-2023 (USD Million)
TABLE 29 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015-2023 (USD Million)
TABLE 30 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FOR ACADEMIC RESEARCH INSTITUTES CENTERS, BY REGION, 2015-2023 (USD Million)
TABLE 31 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, 2017-2023 (USD Million)
TABLE 32 AMERICAS: AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, 2016-2023 (USD Million)
TABLE 33 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 34 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 35 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 36 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 37 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 38 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 39 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 40 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 41 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 42 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 43 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 44 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 45 AMERICAS AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 46 North America AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 47 North America AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 48 North America AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 49 North America AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 50 North America AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 51 North America AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 52 North America AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 53 North America AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 54 North America AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 55 North America AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 56 North America AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 57 North America AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 58 North America AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 59 U.S. AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 60 U.S. AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 61 U.S. AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 62 U.S. AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 63 U.S. AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 64 U.S. AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 65 U.S. AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 66 U.S. AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 67 U.S. AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 68 U.S. AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 69 U.S. AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 70 U.S. AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 71 U.S. AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 72 Canada AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 73 Canada AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 74 Canada AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 75 Canada AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 76 Canada AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 77 Canada AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 78 Canada AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 79 Canada AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 80 Canada AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 81 Canada AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 82 Canada AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 83 Canada AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 84 Canada AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 85 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 86 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 87 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 88 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 89 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 90 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 91 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 92 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 93 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 94 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 95 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 96 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 97 SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 98 EUROPE: AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, 2017-2023 (USD Million)
TABLE 99 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 100 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 101 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 102 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 103 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 104 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 105 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 106 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 107 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 108 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 109 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 110 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 111 EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 112 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 113 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 114 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 115 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 116 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 117 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 118 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 119 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 120 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 121 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 122 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 123 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 124 WESTERN EUROPE AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 125 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 126 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 127 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 128 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 129 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 130 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 131 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 132 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 133 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 134 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 135 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 136 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 137 GERMANY AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 138 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 139 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 140 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 141 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 142 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 143 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 144 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 145 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 146 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 147 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 148 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 149 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)
TABLE 150 FRANCE AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER 2015-2023 (USD Million)
TABLE 151 U.K AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2015-2023 (USD Million)
TABLE 152 U.K AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2015-2023 (USD Million)
TABLE 153 U.K AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2015-2023 (USD Million)
TABLE 154 U.K AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2015-2023 (USD Million)
TABLE 155 U.K AGE-RELATED MACULAR DEGENERATION MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 156 U.K AGE-RELATED MACULAR DEGENERATION MARKET FOR WET AMD TREATMENT, BY TYPE, 2015-2023 (USD Million)
TABLE 157 U.K AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTI- VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY TYPE 2015-2023 (USD Million)
TABLE 158 U.K AGE-RELATED MACULAR DEGENERATION MARKET FOR DRY AGE RELATED MACULAR DEGENERATION, BY TYPE 2015-2023 (USD Million)
TABLE 159 U.K AGE-RELATED MACULAR DEGENERATION MARKET FOR NUTRITION THERAPY, BY TYPE 2015-2023 (USD Million)
TABLE 160 U.K AGE-RELATED MACULAR DEGENERATION MARKET FOR ANTIOXIDANTS, BY TYPE 2015-2023 (USD Million)
TABLE 161 U.K AGE-RELATED MACULAR DEGENERATION MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD Million)
TABLE 162 U.K AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD Million)

LIST OF FIGURE

List of Figures:

FIGURE 1 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 MARKET DYNAMICS ANALYSIS OF GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET
FIGURE 5 SUPPLY CHAIN: AGE-RELATED MACULAR DEGENERATION MARKET
FIGURE 7 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2017 (% SHARE)
FIGURE 8 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2017 (% SHARE)
FIGURE 9 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY STAGES, 2017 & 2023
FIGURE 10 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2017 (% SHARE)
FIGURE 11 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY AGE GROUP, 2017 & 2023
FIGURE 12 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2017 (% SHARE)
FIGURE 13 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY DIAGNOSIS AND TREATMENT, 2017 & 2023
FIGURE 14 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION, 2017 (% SHARE)
FIGURE 15 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY ROUTE OF ADMINISTRATION, 2017 & 2023
FIGURE 16 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER, 2017 (% SHARE)
FIGURE 17 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY END USER, 2017 & 2023
FIGURE 18 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, 2017 & 2023 (USD Million)
FIGURE 19 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, 2017 (% SHARE)
FIGURE 20 AMERICAS: AGE-RELATED MACULAR DEGENERATION MARKET SHARE, BY REGION, 2017 (%)
FIGURE 21 EUROPE: AGE-RELATED MACULAR DEGENERATION MARKET SHARE, BY REGION, 2017 (%)
FIGURE 22 ASIA PACIFIC: AGE-RELATED MACULAR DEGENERATION MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 23 THE MIDDLE EAST AND AFRICA: AGE-RELATED MACULAR DEGENERATION MARKET SHARE, BY REGION, 2017 (%)
FIGURE 24 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET, MARKET SHARE ANALYSIS 2017 (%)
FIGURE 25 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET: KEY STRATEGIC ANALYSIS 2017 (%)